Terms

Continuous glucose monitoring

Follow the latest coverage, related explainers and connected technology stories.

Latest coverage

CN
Ascensia Leads $36 Million Funding Round for Company Developing a Continuous Glucose Sensor

Ascensia Leads $36 Million Funding Round for Company Developing a Continuous Glucose Sensor

UK-based Sava Technologies raised $36 million in a Series B round led by Ascensia Diabetes Care, which also received exclusive rights to market and distribute the sensor in Europe. The company aims to launch a wearable sensor after conducting a pivotal trial and seek CE marking within the next two years.

CN
Abbott Receives U.S. Authorization for Sensor That Monitors Glucose and Ketones Together

Abbott Receives U.S. Authorization for Sensor That Monitors Glucose and Ketones Together

The U.S. Food and Drug Administration granted Abbott de novo authorization for the Libre Duo 10 Day wearable sensor, which can continuously monitor glucose and ketones in people with diabetes. The company plans to launch it in the United States during 2026, while its price and insurance coverage remain undisclosed.

CN
Five Questions About Abbott’s Glucose and Ketone Monitoring Sensor

Five Questions About Abbott’s Glucose and Ketone Monitoring Sensor

Abbott is preparing to launch Libre Duo, a sensor that combines glucose and ketone measurement, after receiving the CE mark and submitting an application to the FDA. The device raises practical questions about eligible populations, interpreting readings, educating users, cost, and the limits of relying on ketones alone.

CN
Senseonics Completes Transfer of Eversense 365 Sales to Internal Management and Plans Fully Implantable Sensor

Senseonics Completes Transfer of Eversense 365 Sales to Internal Management and Plans Fully Implantable Sensor

Senseonics has completed the transfer of marketing and sales operations for the Eversense 365 continuous glucose monitor from Ascensia Diabetes Care to its internal teams in the United States and Europe, coinciding with record revenue of $14.5 million in the second quarter. The company is developing a fully implantable version of the sensor capable of communicating directly with a phone for one year.